A Comparative Study of Brain Structure and Amyloid Load in MCI Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03773185 |
Recruitment Status :
Suspended
(Low recruitment rate)
First Posted : December 12, 2018
Last Update Posted : January 27, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Older people with DM are at greater risk of cognitive decline than their counterparts with DM. Cognitive impairment in older people with DM may be associated with non-AD related brain atrophy and white matter disease. The investigators therefore propose to compare DM and non-DM older people with amnesic MCI in brian volumes, white matter disease and amyloid load.
30 older people with aMCI, 30 older people with aMCI and DM, age 65-85 will be recruited. They all will have amyloid PET scan and MRI brain scan.
Condition or disease |
---|
Mild Cognitive Impairment |
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 60 participants |
Observational Model: | Cohort |
Time Perspective: | Cross-Sectional |
Target Follow-Up Duration: | 1 Month |
Official Title: | A Comparative Study of Brain Structure and Amyloid Load Between Cognitively Impaired Older People With or Without Diabetes Mellitus |
Actual Study Start Date : | December 15, 2018 |
Actual Primary Completion Date : | October 31, 2020 |
Estimated Study Completion Date : | October 31, 2021 |
- Amyloid load [ Time Frame: Two years ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 65 Years to 85 Years (Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- MCI patients
Exclusion Criteria:
- Patients with depression

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03773185
Hong Kong | |
The Chinese University of Hong Kong | |
Hong Kong, Hong Kong |
Principal Investigator: | Timothy Kwok, MD | Chinese University of Hong Kong |
Responsible Party: | Timothy Kwok, Professor, Chinese University of Hong Kong |
ClinicalTrials.gov Identifier: | NCT03773185 |
Other Study ID Numbers: |
2018.454 |
First Posted: | December 12, 2018 Key Record Dates |
Last Update Posted: | January 27, 2021 |
Last Verified: | July 2020 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Cognitive Dysfunction Cognition Disorders Neurocognitive Disorders Mental Disorders |